AKE 0.00% $9.83 allkem limited

Allkem General Discussion, page-4260

  1. 7,822 Posts.
    lightbulb Created with Sketch. 2384
    Some big comments made by Paul, i would expect some upgrades coming from the research houses. Will post transcript when i get it.

    The main comment that stood out was:

    "I expect 2024 contract prices to be higher then 2023". He had a high degree of confidence in this and given Livent have 70% of pricing fixed in their contracts this a huge comment. 2023 prices were set into this higher pricing environment which enabled them to upgrade in the first place. Paul also mentioned they had factored the weaker prices into previously upgraded guidance and forecasts for 2024 with the Allkem/newco model.

    Volume growth remains on track, so higher prices for 2024 seemingly like a certainty given Pauls words, seems like there could be some catch up in bankers models. Seemed like a lot of questioners didnt understand how Livents contracts worked and didnt believe it could remain so strong.

    Were some other very interesting bits worth listening to as well. Encourage others to listen to the QandA.
    Last edited by pastperformer: 04/08/23
 
watchlist Created with Sketch. Add AKE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.